| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R KIR2DS2 NMUR2 PTCH1 GPR101 GRM4 IL18R1 CLEC12A OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 IGF2R OR52A5 ACKR3 OR52D1 OR52N2 OR5H8 AGTR2 OR52E4 SCTR ADGRE5 TACR1 TAS2R60 OR51G1 KIR2DS1 OR52K2 KIR2DS4 KIR2DS5 KIR3DS1 ALK OR52B2 GPR45 | 5.06e-26 | 1353 | 137 | 52 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 GRM4 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 OR5H8 AGTR2 OR52E4 SCTR ADGRE5 TACR1 TAS2R60 OR51G1 OR52K2 OR52B2 GPR45 | 3.34e-24 | 884 | 137 | 42 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | NPBWR1 NPBWR2 PRLHR MLNR MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 AGTR2 SCTR TACR1 | 3.98e-13 | 133 | 137 | 14 | GO:0008528 |
| GeneOntologyMolecularFunction | peptide receptor activity | NPBWR1 NPBWR2 PRLHR MLNR MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 AGTR2 SCTR TACR1 | 8.14e-13 | 140 | 137 | 14 | GO:0001653 |
| GeneOntologyMolecularFunction | melanocortin receptor activity | 3.15e-08 | 6 | 137 | 4 | GO:0004977 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.82e-07 | 37 | 137 | 6 | GO:0042923 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.64e-06 | 431 | 137 | 14 | GO:0004984 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.65e-06 | 53 | 137 | 6 | GO:0008188 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.08e-05 | 7 | 137 | 3 | GO:0004985 | |
| GeneOntologyMolecularFunction | hormone binding | 7.74e-05 | 103 | 137 | 6 | GO:0042562 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 1.40e-04 | 3 | 137 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | melanocyte-stimulating hormone receptor activity | 1.40e-04 | 3 | 137 | 2 | GO:0004980 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 2.13e-04 | 43 | 137 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 3.43e-04 | 190 | 137 | 7 | GO:0004252 | |
| GeneOntologyMolecularFunction | peptide binding | 3.55e-04 | 318 | 137 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 4.61e-04 | 5 | 137 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 5.74e-04 | 207 | 137 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 6.61e-04 | 212 | 137 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.32e-04 | 26 | 137 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | G protein-coupled adenosine receptor activity | 9.59e-04 | 7 | 137 | 2 | GO:0001609 | |
| GeneOntologyMolecularFunction | immune receptor activity | 9.80e-04 | 165 | 137 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | C-X-C chemokine receptor activity | 1.27e-03 | 8 | 137 | 2 | GO:0016494 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | LRRC8C ANO9 SCN11A NMUR2 SLC26A8 MLC1 SCN3A SCN10A KCNMB4 KCNT1 | 1.28e-03 | 459 | 137 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 1.63e-03 | 9 | 137 | 2 | GO:0032795 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51T1 NPBWR1 NPBWR2 SCN11A PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R DGKE NMUR2 GPR101 GRM4 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 GPR180 OR6F1 ADORA1 ADORA2A TGM2 OR52K1 OR2A12 IGF2R OR52A5 ACKR3 OR52D1 OR52N2 OR5H8 AGTR2 OR52E4 SCTR ADGRE5 TACR1 TAS2R60 OR51G1 OR52K2 ALK OR52B2 GPR45 | 4.50e-22 | 1395 | 139 | 48 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | DRD2 OXER1 DRD3 MC1R MC2R MC4R MC5R GPR101 GRM4 EDNRA FFAR4 OPRK1 ADORA1 ADORA2A SCTR ADGRE5 | 1.01e-10 | 286 | 139 | 16 | GO:0007188 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51T1 SCN11A OR52N1 FFAR4 OR52E2 OR6F1 ADORA1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 SCN10A OR52E4 TAS2R60 OR51G1 OR52K2 OR52B2 | 1.38e-08 | 582 | 139 | 19 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51T1 SCN11A OR52N1 FFAR4 OR52E2 OR6F1 ADORA1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 SCN10A OR52E4 KCNMB4 TACR1 TAS2R60 OR51G1 OR52K2 OR52B2 | 1.65e-08 | 722 | 139 | 21 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR51T1 SCN11A DRD2 MC1R NMUR2 OR52N1 FFAR4 OPRK1 OR52E2 OR6F1 ADORA1 ADORA2A COL18A1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 SCN10A OR52E4 TAS2R60 OR51G1 OR52K2 OR52B2 | 4.91e-08 | 1072 | 139 | 25 | GO:0007600 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | DRD2 DRD3 MC1R MC2R MC4R MC5R GPR101 FFAR4 ADORA2A SCTR ADGRE5 | 7.18e-08 | 191 | 139 | 11 | GO:0007189 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51T1 OR52N1 FFAR4 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 KCNMB4 TAS2R60 OR51G1 OR52K2 OR52B2 | 9.27e-08 | 524 | 139 | 17 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51T1 DRD2 OR52N1 FFAR4 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 TAS2R60 OR51G1 OR52K2 OR52B2 | 1.71e-07 | 547 | 139 | 17 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51T1 OR52N1 FFAR4 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 TAS2R60 OR51G1 OR52K2 OR52B2 | 1.82e-07 | 485 | 139 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 2.96e-07 | 133 | 139 | 9 | GO:0007200 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51T1 DRD2 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 5.98e-07 | 465 | 139 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.37e-06 | 432 | 139 | 14 | GO:0050911 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.87e-06 | 86 | 139 | 7 | GO:0007193 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 2.52e-06 | 128 | 139 | 8 | GO:0050795 | |
| GeneOntologyBiologicalProcess | secretion | RHBDD1 SCN11A DRD2 DRD3 RHBDF2 MC4R MYO18A SYT9 NMUR2 GRM4 EDNRA FFAR4 OPRK1 EFR3A ADORA1 ADORA2A TGM2 AGTR2 TMEM132A KCNMB4 ADAM17 TACR1 OC90 | 6.96e-06 | 1221 | 139 | 23 | GO:0046903 |
| GeneOntologyBiologicalProcess | renal system process | 7.78e-06 | 149 | 139 | 8 | GO:0003014 | |
| GeneOntologyBiologicalProcess | signal release | DRD2 DRD3 MC4R SYT9 GRM4 FFAR4 OPRK1 EFR3A ADORA1 ADORA2A TGM2 AGTR2 TMEM132A KCNMB4 ADAM17 TACR1 | 8.67e-06 | 653 | 139 | 16 | GO:0023061 |
| GeneOntologyBiologicalProcess | feeding behavior | 1.43e-05 | 162 | 139 | 8 | GO:0007631 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 1.56e-05 | 79 | 139 | 6 | GO:0050432 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | LRRC8C DRD2 DRD3 NMUR2 MFSD12 SLC7A8 ADORA1 ADORA2A SLC26A8 AGTR2 ABCD2 OC90 | 2.23e-05 | 410 | 139 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | LRRC8C DRD2 DRD3 NMUR2 MFSD12 SLC7A8 ADORA1 ADORA2A SLC26A8 AGTR2 ABCD2 OC90 | 2.34e-05 | 412 | 139 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | response to pain | 2.37e-05 | 51 | 139 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | behavior | SCN11A PRLHR DRD2 DRD3 HTR2B MC1R MC4R NMUR2 GRM4 ZZEF1 OPRK1 ADORA1 ADORA2A SCN3A AGTR2 SCN10A TACR1 ALK | 3.12e-05 | 891 | 139 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 3.17e-05 | 132 | 139 | 7 | GO:0006661 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 3.17e-05 | 132 | 139 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | eating behavior | 3.75e-05 | 56 | 139 | 5 | GO:0042755 | |
| GeneOntologyBiologicalProcess | icosanoid secretion | 3.75e-05 | 56 | 139 | 5 | GO:0032309 | |
| GeneOntologyBiologicalProcess | response to amine | 4.45e-05 | 58 | 139 | 5 | GO:0014075 | |
| GeneOntologyBiologicalProcess | cellular response to serotonin | 4.51e-05 | 2 | 139 | 2 | GO:1904015 | |
| GeneOntologyBiologicalProcess | response to serotonin | 4.51e-05 | 2 | 139 | 2 | GO:1904014 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC17A2 LRRC8C DRD2 DRD3 NMUR2 MFSD12 SLC7A8 ADORA1 ADORA2A SLC26A8 AGTR2 ABCD2 OC90 | 4.68e-05 | 515 | 139 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | catecholamine transport | 4.74e-05 | 96 | 139 | 6 | GO:0051937 | |
| GeneOntologyBiologicalProcess | regulation of dopamine receptor signaling pathway | 4.75e-05 | 11 | 139 | 3 | GO:0060159 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle, sleep | 5.40e-05 | 31 | 139 | 4 | GO:0045187 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 5.63e-05 | 99 | 139 | 6 | GO:0032465 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 5.68e-05 | 61 | 139 | 5 | GO:0007187 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.13e-05 | 32 | 139 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 6.70e-05 | 201 | 139 | 8 | GO:0051302 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, sleep | 6.94e-05 | 33 | 139 | 4 | GO:0050802 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 7.16e-05 | 64 | 139 | 5 | GO:1903351 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 7.83e-05 | 105 | 139 | 6 | GO:0019233 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 8.15e-05 | 13 | 139 | 3 | GO:0038003 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 8.15e-05 | 13 | 139 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | response to dopamine | 8.31e-05 | 66 | 139 | 5 | GO:1903350 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle | 8.79e-05 | 35 | 139 | 4 | GO:0042749 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 8.93e-05 | 67 | 139 | 5 | GO:0050433 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 9.59e-05 | 68 | 139 | 5 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 9.59e-05 | 68 | 139 | 5 | GO:0071870 | |
| GeneOntologyBiologicalProcess | secretion by cell | SCN11A DRD2 DRD3 RHBDF2 MC4R MYO18A SYT9 GRM4 FFAR4 OPRK1 EFR3A ADORA1 ADORA2A TGM2 AGTR2 TMEM132A KCNMB4 ADAM17 TACR1 | 9.72e-05 | 1064 | 139 | 19 | GO:0032940 |
| GeneOntologyBiologicalProcess | arachidonate secretion | 9.84e-05 | 36 | 139 | 4 | GO:0050482 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle process | 9.84e-05 | 36 | 139 | 4 | GO:0022410 | |
| GeneOntologyBiologicalProcess | arachidonate transport | 9.84e-05 | 36 | 139 | 4 | GO:1903963 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renin-angiotensin | 1.03e-04 | 14 | 139 | 3 | GO:0002016 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by renin-angiotensin | 1.10e-04 | 37 | 139 | 4 | GO:0003081 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.22e-04 | 38 | 139 | 4 | GO:0050951 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | DRD2 DRD3 HTR2B GPR101 GRM4 EDNRA FFAR4 OPRK1 ADORA1 NOX1 ACKR3 MAP4K1 ADAM17 | 1.32e-04 | 571 | 139 | 13 | GO:0043410 |
| GeneOntologyBiologicalProcess | icosanoid transport | 1.34e-04 | 73 | 139 | 5 | GO:0071715 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 1.34e-04 | 73 | 139 | 5 | GO:0071869 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.36e-04 | 116 | 139 | 6 | GO:0015844 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid transport | 1.43e-04 | 74 | 139 | 5 | GO:0015909 | |
| GeneOntologyBiologicalProcess | response to monoamine | 1.43e-04 | 74 | 139 | 5 | GO:0071867 | |
| GeneOntologyBiologicalProcess | sleep | 1.50e-04 | 40 | 139 | 4 | GO:0030431 | |
| GeneOntologyBiologicalProcess | response to amphetamine | 1.50e-04 | 40 | 139 | 4 | GO:0001975 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 1.56e-04 | 170 | 139 | 7 | GO:0046488 | |
| GeneOntologyBiologicalProcess | dopamine secretion | 1.65e-04 | 41 | 139 | 4 | GO:0014046 | |
| GeneOntologyBiologicalProcess | regulation of lipid catabolic process | 1.84e-04 | 78 | 139 | 5 | GO:0050994 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 1.96e-04 | 124 | 139 | 6 | GO:0007218 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 1.96e-04 | 124 | 139 | 6 | GO:0003073 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle | 1.99e-04 | 43 | 139 | 4 | GO:0042745 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 2.04e-04 | 125 | 139 | 6 | GO:0051952 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 2.37e-04 | 45 | 139 | 4 | GO:0032228 | |
| GeneOntologyBiologicalProcess | negative regulation of dopamine receptor signaling pathway | 2.68e-04 | 4 | 139 | 2 | GO:0060160 | |
| GeneOntologyBiologicalProcess | response to alcohol | 2.71e-04 | 312 | 139 | 9 | GO:0097305 | |
| GeneOntologyBiologicalProcess | export from cell | SCN11A DRD2 DRD3 RHBDF2 MC4R MYO18A SYT9 GRM4 FFAR4 OPRK1 EFR3A ADORA1 ADORA2A TGM2 AGTR2 TMEM132A KCNMB4 ADAM17 TACR1 | 2.73e-04 | 1153 | 139 | 19 | GO:0140352 |
| GeneOntologyBiologicalProcess | fatty acid transport | 2.75e-04 | 132 | 139 | 6 | GO:0015908 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 2.86e-04 | 133 | 139 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | prepulse inhibition | 3.14e-04 | 20 | 139 | 3 | GO:0060134 | |
| GeneOntologyBiologicalProcess | amine transport | 3.35e-04 | 137 | 139 | 6 | GO:0015837 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor internalization | 3.64e-04 | 21 | 139 | 3 | GO:0002031 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 3.86e-04 | 51 | 139 | 4 | GO:0001990 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.97e-04 | 92 | 139 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 4.06e-04 | 142 | 139 | 6 | GO:0018958 | |
| GeneOntologyBiologicalProcess | circulatory system process | SCN11A DRD2 DRD3 HTR2B EDNRA SLC7A8 ADORA1 ADORA2A NOX1 SCN3A AGTR2 SCN10A KCNMB4 TACR1 | 4.40e-04 | 733 | 139 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.47e-04 | 202 | 139 | 7 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.47e-04 | 202 | 139 | 7 | GO:0097746 | |
| GeneOntologyBiologicalProcess | blood circulation | SCN11A DRD2 DRD3 HTR2B EDNRA ADORA1 ADORA2A NOX1 SCN3A AGTR2 SCN10A KCNMB4 TACR1 | 4.48e-04 | 648 | 139 | 13 | GO:0008015 |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.60e-04 | 203 | 139 | 7 | GO:0035150 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | NPBWR1 DRD2 DRD3 HTR2B SYT9 DGKE GRM4 ZZEF1 CNIH3 OPRK1 EFR3A ADORA1 ADORA2A SCTR KCNMB4 TACR1 | 5.45e-04 | 931 | 139 | 16 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | NPBWR1 DRD2 DRD3 HTR2B SYT9 DGKE GRM4 ZZEF1 CNIH3 OPRK1 EFR3A ADORA1 ADORA2A SCTR KCNMB4 TACR1 | 5.45e-04 | 931 | 139 | 16 | GO:0007268 |
| GeneOntologyBiologicalProcess | behavioral response to cocaine | 5.46e-04 | 24 | 139 | 3 | GO:0048148 | |
| GeneOntologyBiologicalProcess | grooming behavior | 5.46e-04 | 24 | 139 | 3 | GO:0007625 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 5.46e-04 | 24 | 139 | 3 | GO:0001976 | |
| GeneOntologyBiologicalProcess | dopamine transport | 5.91e-04 | 57 | 139 | 4 | GO:0015872 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | NPBWR1 DRD2 DRD3 HTR2B SYT9 DGKE GRM4 ZZEF1 CNIH3 OPRK1 EFR3A ADORA1 ADORA2A SCTR KCNMB4 TACR1 | 5.98e-04 | 939 | 139 | 16 | GO:0099537 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 6.18e-04 | 25 | 139 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 6.30e-04 | 214 | 139 | 7 | GO:1903531 | |
| GeneOntologyBiologicalProcess | negative regulation of circadian sleep/wake cycle, sleep | 6.64e-04 | 6 | 139 | 2 | GO:0042321 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 6.64e-04 | 6 | 139 | 2 | GO:0007195 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 6.84e-04 | 217 | 139 | 7 | GO:0046474 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 6.95e-04 | 26 | 139 | 3 | GO:0050965 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.83e-04 | 17 | 139 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | C-fiber | 2.61e-04 | 4 | 139 | 2 | GO:0044299 | |
| MousePheno | abnormal touch/ nociception | SCN11A PRLHR MC1R NMUR2 PHGDH OPRK1 ADORA1 ADORA2A AGTR2 TMEM132A SCN10A TACR1 KCNT1 | 1.68e-06 | 376 | 96 | 13 | MP:0001968 |
| MousePheno | abnormal behavioral response to addictive substance | 6.27e-06 | 102 | 96 | 7 | MP:0009748 | |
| MousePheno | impaired behavioral response to addictive substance | 1.35e-05 | 45 | 96 | 5 | MP:0009750 | |
| MousePheno | abnormal pain threshold | SCN11A PRLHR MC1R NMUR2 OPRK1 ADORA1 ADORA2A AGTR2 SCN10A TACR1 | 1.45e-05 | 267 | 96 | 10 | MP:0001970 |
| MousePheno | abnormal behavioral response to alcohol | 2.00e-05 | 24 | 96 | 4 | MP:0020157 | |
| MousePheno | impaired behavioral response to morphine | 3.64e-05 | 10 | 96 | 3 | MP:0009757 | |
| MousePheno | short mandibular coronoid process | 4.67e-05 | 2 | 96 | 2 | MP:0030284 | |
| MousePheno | abnormal behavioral response to xenobiotic | 5.06e-05 | 309 | 96 | 10 | MP:0009745 | |
| MousePheno | abnormal behavioral response to morphine | 8.54e-05 | 13 | 96 | 3 | MP:0020159 | |
| MousePheno | abnormal conditioned place preference behavior | 9.29e-05 | 35 | 96 | 4 | MP:0009711 | |
| MousePheno | abnormal mechanical nociception | 1.04e-04 | 36 | 96 | 4 | MP:0002734 | |
| MousePheno | increased circulating adrenocorticotropin level | 1.08e-04 | 14 | 96 | 3 | MP:0001748 | |
| MousePheno | abnormal drinking behavior | 1.10e-04 | 159 | 96 | 7 | MP:0001422 | |
| MousePheno | impaired behavioral response to xenobiotic | 2.62e-04 | 83 | 96 | 5 | MP:0009747 | |
| MousePheno | abnormal tricuspid valve cusp morphology | 2.78e-04 | 4 | 96 | 2 | MP:0010622 | |
| MousePheno | increased susceptibility to weight gain | 2.81e-04 | 131 | 96 | 6 | MP:0005455 | |
| MousePheno | abnormal circulating corticosterone level | 3.44e-04 | 88 | 96 | 5 | MP:0005345 | |
| MousePheno | abnormal fluid intake | 3.44e-04 | 136 | 96 | 6 | MP:0011947 | |
| Domain | GPCR_Rhodpsn_7TM | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 AGTR2 OR52E4 TACR1 OR51G1 OR52K2 OR52B2 GPR45 | 2.96e-22 | 670 | 139 | 37 | IPR017452 |
| Domain | 7tm_1 | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 AGTR2 OR52E4 TACR1 OR51G1 OR52K2 OR52B2 GPR45 | 4.23e-22 | 677 | 139 | 37 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 AGTR2 OR52E4 TACR1 OR51G1 OR52K2 OR52B2 GPR45 | 6.33e-22 | 685 | 139 | 37 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 AGTR2 OR52E4 TACR1 OR51G1 OR52K2 OR52B2 GPR45 | 8.53e-22 | 691 | 139 | 37 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51T1 NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GPR101 OR52N1 EDNRA FFAR4 OPRK1 OR52E2 CXCR5 OR6F1 ADORA1 ADORA2A OR52K1 OR2A12 OR52A5 ACKR3 OR52D1 OR52N2 AGTR2 OR52E4 TACR1 OR51G1 OR52K2 OR52B2 GPR45 | 8.97e-22 | 692 | 139 | 37 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | NPBWR2 PRLHR DRD2 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 OPRK1 OR6F1 ADORA1 ADORA2A OR52A5 | 1.90e-16 | 112 | 139 | 16 | SM01381 |
| Domain | Melcrt_ACTH_rcpt | 4.36e-08 | 6 | 139 | 4 | IPR001671 | |
| Domain | Olfact_rcpt | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR52E4 OR51G1 OR52K2 OR52B2 | 7.72e-06 | 393 | 139 | 13 | IPR000725 |
| Domain | Na_channel_asu | 4.66e-05 | 10 | 139 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 4.66e-05 | 10 | 139 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 4.66e-05 | 10 | 139 | 3 | PF06512 | |
| Domain | Neuropept_B/W_rcpt | 5.50e-05 | 2 | 139 | 2 | IPR009150 | |
| Domain | Melancort_rcpt | 1.64e-04 | 3 | 139 | 2 | IPR001908 | |
| Domain | Adenosn_rcpt | 3.27e-04 | 4 | 139 | 2 | IPR001634 | |
| Domain | ATII_rcpt | 5.42e-04 | 5 | 139 | 2 | IPR000248 | |
| Domain | Dopamine_rcpt | 5.42e-04 | 5 | 139 | 2 | IPR000929 | |
| Domain | PH-BEACH_dom | 1.50e-03 | 8 | 139 | 2 | IPR023362 | |
| Domain | Peptidase_S54_rhomboid | 1.50e-03 | 8 | 139 | 2 | IPR002610 | |
| Domain | - | 1.50e-03 | 8 | 139 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.50e-03 | 8 | 139 | 2 | PS51783 | |
| Domain | BEACH_dom | 1.91e-03 | 9 | 139 | 2 | IPR000409 | |
| Domain | Rhomboid | 1.91e-03 | 9 | 139 | 2 | PF01694 | |
| Domain | Peptidase_S54_rhomboid_dom | 1.91e-03 | 9 | 139 | 2 | IPR022764 | |
| Domain | BEACH | 1.91e-03 | 9 | 139 | 2 | PS50197 | |
| Domain | Beach | 1.91e-03 | 9 | 139 | 2 | PF02138 | |
| Domain | - | 1.91e-03 | 9 | 139 | 2 | 1.10.1540.10 | |
| Domain | - | 1.91e-03 | 9 | 139 | 2 | 1.20.1540.10 | |
| Domain | Beach | 1.91e-03 | 9 | 139 | 2 | SM01026 | |
| Domain | ig | 3.01e-03 | 190 | 139 | 6 | PF00047 | |
| Domain | Immunoglobulin | 3.01e-03 | 190 | 139 | 6 | IPR013151 | |
| Domain | ARM-type_fold | 3.91e-03 | 339 | 139 | 8 | IPR016024 | |
| Domain | ARM-like | 4.13e-03 | 270 | 139 | 7 | IPR011989 | |
| Domain | FN_type2_col-bd | 4.72e-03 | 14 | 139 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.72e-03 | 14 | 139 | 2 | PS51092 | |
| Domain | Dynein_HC_stalk | 4.72e-03 | 14 | 139 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.72e-03 | 14 | 139 | 2 | IPR013602 | |
| Domain | TUDOR | 4.72e-03 | 14 | 139 | 2 | PF00567 | |
| Domain | DHC_N2 | 4.72e-03 | 14 | 139 | 2 | PF08393 | |
| Domain | MT | 4.72e-03 | 14 | 139 | 2 | PF12777 | |
| Domain | fn2 | 4.72e-03 | 14 | 139 | 2 | PF00040 | |
| Domain | FN2_1 | 4.72e-03 | 14 | 139 | 2 | PS00023 | |
| Domain | FN2 | 4.72e-03 | 14 | 139 | 2 | SM00059 | |
| Domain | DHC_fam | 5.42e-03 | 15 | 139 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.42e-03 | 15 | 139 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 5.42e-03 | 15 | 139 | 2 | PF03028 | |
| Domain | - | 6.39e-03 | 222 | 139 | 6 | 1.25.10.10 | |
| Pathway | WP_GPCRS_NONODORANT | NPBWR1 PRLHR DRD2 DRD3 HTR2B MC1R MC2R MC4R MC5R NMUR2 GRM4 EDNRA FFAR4 OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 SCTR ADGRE5 TACR1 | 1.55e-16 | 266 | 113 | 22 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 PTCH1 GRM4 EDNRA FFAR4 OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 SCTR ADGRE5 TACR1 TAS2R60 | 2.58e-16 | 463 | 113 | 27 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 EDNRA FFAR4 OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 TACR1 | 1.42e-14 | 330 | 113 | 22 | M18334 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPBWR1 NPBWR2 PRLHR DRD2 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 GPR45 | 1.72e-14 | 260 | 113 | 20 | M39397 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPBWR1 NPBWR2 PRLHR DRD2 OXER1 DRD3 HTR2B MLNR RGS22 MC1R MC2R MC4R MC5R DGKE NMUR2 PTCH1 GRM4 EDNRA FFAR4 OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 SCTR ADGRE5 TACR1 TAS2R60 GPR45 | 1.90e-14 | 702 | 113 | 30 | M746 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | NPBWR1 NPBWR2 PRLHR DRD2 DRD3 HTR2B MLNR MC1R MC2R MC4R MC5R NMUR2 GRM4 EDNRA OPRK1 ADORA1 ADORA2A AGTR2 SCTR TACR1 | 4.05e-14 | 272 | 113 | 20 | M13380 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPBWR1 PRLHR DRD2 DRD3 HTR2B MC1R MC2R MC4R MC5R NMUR2 GRM4 EDNRA OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 SCTR ADGRE5 TACR1 TAS2R60 | 3.02e-12 | 430 | 113 | 22 | MM15160 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPBWR1 PRLHR DRD2 DRD3 HTR2B MC1R MC2R MC4R MC5R DGKE NMUR2 GRM4 EDNRA FFAR4 OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 SCTR ADGRE5 TACR1 TAS2R60 GPR45 | 3.68e-11 | 646 | 113 | 25 | MM14962 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | NPBWR1 NPBWR2 PRLHR MLNR MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 CXCR5 ACKR3 AGTR2 TACR1 | 4.83e-11 | 197 | 113 | 15 | M12289 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | NPBWR1 PRLHR DRD2 DRD3 HTR2B MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 CXCR5 ADORA1 ADORA2A ACKR3 AGTR2 TACR1 | 1.46e-10 | 333 | 113 | 18 | MM14963 |
| Pathway | WP_GPCRS_PEPTIDE | 4.28e-09 | 70 | 113 | 9 | MM15959 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | NPBWR1 PRLHR MC1R MC2R MC4R MC5R NMUR2 EDNRA OPRK1 CXCR5 ACKR3 AGTR2 TACR1 | 5.89e-09 | 197 | 113 | 13 | MM14970 |
| Pathway | WP_PEPTIDE_GPCRS | 7.99e-09 | 75 | 113 | 9 | M39696 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | DRD3 HTR2B MC1R MC2R MC4R MC5R OPRK1 CXCR5 ADORA2A ACKR3 AGTR2 GPR45 | 3.02e-08 | 186 | 113 | 12 | MM15994 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPBWR1 NPBWR2 OXER1 DRD3 RGS22 NMUR2 GRM4 OPRK1 CXCR5 ADORA1 ACKR3 AGTR2 TAS2R60 | 1.35e-06 | 314 | 113 | 13 | M600 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR52E4 OR51G1 OR52K2 OR52B2 | 1.39e-05 | 389 | 113 | 13 | M14091 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR52E4 OR51G1 OR52K2 OR52B2 | 2.89e-05 | 417 | 113 | 13 | M4072 |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.19e-05 | 46 | 113 | 5 | M27151 | |
| Pathway | REACTOME_ALK_MUTANTS_BIND_TKIS | 1.05e-04 | 12 | 113 | 3 | M42522 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPBWR1 DRD3 NMUR2 GRM4 OPRK1 CXCR5 ADORA1 ACKR3 AGTR2 TAS2R60 | 1.08e-04 | 289 | 113 | 10 | MM15057 |
| Pathway | WP_GPCRS_OTHER | 1.20e-04 | 96 | 113 | 6 | MM15939 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.50e-04 | 143 | 113 | 7 | MM15055 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51T1 GRM4 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 SCN3A OR52E4 OR51G1 OR52K2 OR52B2 | 1.65e-04 | 636 | 113 | 15 | M41834 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | AANAT SCN11A DRD2 HTR2B MC4R GRM4 PIK3R4 ADORA2A NOX1 SCN3A SCN10A | 1.74e-04 | 367 | 113 | 11 | M48346 |
| Pathway | WP_SLEEP_REGULATION | 2.34e-04 | 38 | 113 | 4 | M39504 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.68e-04 | 157 | 113 | 7 | M4904 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 6.27e-04 | 5 | 113 | 2 | M27301 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 6.27e-04 | 5 | 113 | 2 | M48987 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 6.27e-04 | 5 | 113 | 2 | MM15007 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.81e-03 | 217 | 113 | 7 | M18437 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.91e-03 | 31 | 113 | 3 | M877 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.91e-03 | 31 | 113 | 3 | MM15871 | |
| Pubmed | 1.02e-12 | 5 | 141 | 5 | 19410616 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 1.81e-12 | 11 | 141 | 6 | 19664392 | |
| Pubmed | 3.61e-12 | 12 | 141 | 6 | 20371502 | ||
| Pubmed | 3.61e-12 | 12 | 141 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 3.61e-12 | 12 | 141 | 6 | 19181658 | |
| Pubmed | 3.61e-12 | 12 | 141 | 6 | 20137308 | ||
| Pubmed | 6.69e-12 | 13 | 141 | 6 | 19934297 | ||
| Pubmed | 6.69e-12 | 13 | 141 | 6 | 19120281 | ||
| Pubmed | 6.69e-12 | 13 | 141 | 6 | 18687225 | ||
| Pubmed | NPBWR1 NPBWR2 DRD2 OXER1 DRD3 NMUR2 EDNRA OPRK1 CXCR5 ADORA1 ACKR3 AGTR2 | 1.07e-11 | 179 | 141 | 12 | 18577758 | |
| Pubmed | 1.17e-11 | 14 | 141 | 6 | 19875891 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 1.17e-11 | 14 | 141 | 6 | 19421224 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.17e-11 | 14 | 141 | 6 | 15896204 | |
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 20082646 | ||
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 19850842 | ||
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 20356536 | ||
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 19926642 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 1.94e-11 | 15 | 141 | 6 | 20207982 | |
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 19493232 | ||
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 20643584 | ||
| Pubmed | 1.94e-11 | 15 | 141 | 6 | 19326408 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 19897003 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 19000141 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 20670355 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 18668235 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 19309280 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 3.09e-11 | 16 | 141 | 6 | 19527230 | |
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 20652381 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 19279038 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 17868255 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 18643961 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 20331834 | ||
| Pubmed | 3.09e-11 | 16 | 141 | 6 | 20210919 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 4.76e-11 | 17 | 141 | 6 | 20878400 | |
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 20650299 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 20173784 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 20173792 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 20483367 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 4.76e-11 | 17 | 141 | 6 | 19218127 | |
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 19169284 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 19450876 | ||
| Pubmed | 4.76e-11 | 17 | 141 | 6 | 19761533 | ||
| Pubmed | 5.66e-11 | 8 | 141 | 5 | 18681957 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 7.11e-11 | 18 | 141 | 6 | 19630074 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 7.11e-11 | 18 | 141 | 6 | 19046302 | |
| Pubmed | 7.11e-11 | 18 | 141 | 6 | 20580654 | ||
| Pubmed | 7.11e-11 | 18 | 141 | 6 | 20519398 | ||
| Pubmed | 7.11e-11 | 18 | 141 | 6 | 19846535 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 1.04e-10 | 19 | 141 | 6 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 1.04e-10 | 19 | 141 | 6 | 18778326 | |
| Pubmed | 1.04e-10 | 19 | 141 | 6 | 20600442 | ||
| Pubmed | 1.04e-10 | 19 | 141 | 6 | 18848853 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.27e-10 | 9 | 141 | 5 | 8662091 | |
| Pubmed | 1.27e-10 | 9 | 141 | 5 | 18340360 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 1.48e-10 | 20 | 141 | 6 | 20193031 | |
| Pubmed | 1.48e-10 | 20 | 141 | 6 | 20426625 | ||
| Pubmed | 2.06e-10 | 21 | 141 | 6 | 19861144 | ||
| Pubmed | 2.53e-10 | 10 | 141 | 5 | 21206914 | ||
| Pubmed | 2.82e-10 | 22 | 141 | 6 | 20492596 | ||
| Pubmed | 4.62e-10 | 11 | 141 | 5 | 18830515 | ||
| Pubmed | NPBWR1 NPBWR2 DRD2 DRD3 HTR2B OPRK1 ADORA1 ADORA2A ACKR3 AGTR2 SCTR | 6.62e-10 | 200 | 141 | 11 | 18240029 | |
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 12865302 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR51T1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.52e-09 | 340 | 141 | 13 | 11875048 |
| Pubmed | OR51T1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.52e-09 | 340 | 141 | 13 | 11802173 | |
| Pubmed | OR51T1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.69e-09 | 343 | 141 | 13 | 32295537 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 1.75e-09 | 29 | 141 | 6 | 20082482 | |
| Pubmed | OR51T1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 1.88e-09 | 346 | 141 | 13 | 14611657 | |
| Pubmed | 1.98e-09 | 14 | 141 | 5 | 19489269 | ||
| Pubmed | 1.98e-09 | 14 | 141 | 5 | 18945962 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 2.96e-09 | 15 | 141 | 5 | 17498266 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 20528243 | ||
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 17882223 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 4.30e-09 | 16 | 141 | 5 | 16403292 | |
| Pubmed | 5.88e-09 | 35 | 141 | 6 | 19683555 | ||
| Pubmed | 6.07e-09 | 17 | 141 | 5 | 19032228 | ||
| Pubmed | 8.37e-09 | 18 | 141 | 5 | 20200544 | ||
| Pubmed | 8.37e-09 | 18 | 141 | 5 | 20210918 | ||
| Pubmed | MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. | 8.97e-09 | 7 | 141 | 4 | 19329486 | |
| Pubmed | The structure and evolution of the melanocortin and MCH receptors in fish and mammals. | 8.97e-09 | 7 | 141 | 4 | 12620396 | |
| Pubmed | Effects of recombinant agouti-signaling protein on melanocortin action. | 8.97e-09 | 7 | 141 | 4 | 9058374 | |
| Pubmed | Agouti/melanocortin interactions with leptin pathways in obesity. | 1.79e-08 | 8 | 141 | 4 | 9763877 | |
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 7749980 | ||
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 18074414 | ||
| Pubmed | OR51T1 OR52N1 OR52E2 OR6F1 OR52K1 OR2A12 OR52A5 OR52D1 OR52N2 OR5H8 OR52E4 OR51G1 OR52K2 OR52B2 | 4.89e-08 | 541 | 141 | 14 | 14983052 | |
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 12559621 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 25860801 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8765026 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 19500138 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with pulmonary tuberculosis in Chinese Han. | 6.52e-08 | 3 | 141 | 3 | 22653583 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 23325834 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 29408295 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 1.25e-07 | 12 | 141 | 4 | 17490516 | |
| Pubmed | 2.21e-07 | 33 | 141 | 5 | 17350283 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 25253288 | ||
| Pubmed | Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. | 2.60e-07 | 4 | 141 | 3 | 16476524 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 20576036 | ||
| Pubmed | Exercise-Induced Adaptations to the Mouse Striatal Adenosine System. | 2.60e-07 | 4 | 141 | 3 | 32399024 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 1662665 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 15470082 | ||
| Interaction | ASIP interactions | 2.58e-06 | 16 | 127 | 4 | int:ASIP | |
| Interaction | KIR2DS2 interactions | 3.41e-06 | 37 | 127 | 5 | int:KIR2DS2 | |
| Cytoband | 11p15.4 | DNHD1 OR51T1 SYT9 OR52N1 OR52E2 OR52K1 OR52A5 OR52D1 OR52N2 OR52E4 OR51G1 OR52K2 OR52B2 | 6.66e-14 | 200 | 141 | 13 | 11p15.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | DNHD1 OR51T1 ANO9 SYT9 OR52N1 OR52E2 OR52K1 GTF2H1 OR52A5 OR52D1 OR52N2 OR52E4 OR51G1 OR52K2 OR52B2 | 2.70e-10 | 564 | 141 | 15 | chr11p15 |
| Cytoband | 19q13.4 | 1.74e-07 | 79 | 141 | 6 | 19q13.4 | |
| Cytoband | 18p11.2 | 3.32e-04 | 9 | 141 | 2 | 18p11.2 | |
| Cytoband | 2q24 | 5.06e-04 | 11 | 141 | 2 | 2q24 | |
| Cytoband | 8q24.22 | 1.24e-03 | 17 | 141 | 2 | 8q24.22 | |
| GeneFamily | Olfactory receptors, family 52 | OR52N1 OR52E2 OR52K1 OR52A5 OR52D1 OR52N2 OR52E4 OR52K2 OR52B2 | 1.37e-11 | 49 | 110 | 9 | 165 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 7.73e-10 | 18 | 110 | 6 | 620 | |
| GeneFamily | Melanocortin receptors | 6.46e-09 | 5 | 110 | 4 | 236 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | KIR2DS2 IL18R1 CLEC12A CXCR5 IGF2R CD226 ADGRE5 ADAM17 KIR2DS1 LY75 KIR2DS4 KIR2DS5 ALK | 8.05e-07 | 394 | 110 | 13 | 471 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.79e-05 | 9 | 110 | 3 | 1203 | |
| GeneFamily | Adenosine receptors | 2.18e-04 | 4 | 110 | 2 | 211 | |
| GeneFamily | Dopamine receptors | 3.62e-04 | 5 | 110 | 2 | 181 | |
| GeneFamily | Peptide receptors | 7.55e-04 | 7 | 110 | 2 | 220 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| GeneFamily | Neuropeptide receptors | 1.60e-03 | 10 | 110 | 2 | 854 | |
| GeneFamily | Rhomboid family | 3.18e-03 | 14 | 110 | 2 | 926 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.47e-07 | 94 | 136 | 6 | c73e99890431750b74f984de5c82e33533ab708b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.47e-07 | 94 | 136 | 6 | 1bda61101f45f5c4a68453087b880fdc6d9acfca | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.47e-07 | 94 | 136 | 6 | 9664f74bc0168c92fb8a68cad628323c476f6103 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.05e-06 | 191 | 136 | 7 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-06 | 193 | 136 | 7 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 171 | 136 | 6 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 171 | 136 | 6 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 173 | 136 | 6 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 175 | 136 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 175 | 136 | 6 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-05 | 176 | 136 | 6 | 318dc722b95e269002fb01a0feb91c0c8539e150 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-05 | 176 | 136 | 6 | f6891006d816309edabe75b2abf60675f2958e55 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 179 | 136 | 6 | 55fde77dae7f9e7f3431c3185d14212a25af83df | |
| ToppCell | Adult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.05e-05 | 182 | 136 | 6 | dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 136 | 6 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 2.61e-05 | 190 | 136 | 6 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-05 | 191 | 136 | 6 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 191 | 136 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | Adult-Immune-natural_killer_cell|Adult / Lineage, Cell type, age group and donor | 2.69e-05 | 191 | 136 | 6 | 758ec27e47d7662a5175305e98a1506c6859dbf7 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 191 | 136 | 6 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.77e-05 | 192 | 136 | 6 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.94e-05 | 194 | 136 | 6 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-05 | 195 | 136 | 6 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-05 | 195 | 136 | 6 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.20e-05 | 197 | 136 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-05 | 198 | 136 | 6 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-05 | 198 | 136 | 6 | 9dc91a1101eef649a301f0147ecd5c028a9c2b12 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.39e-05 | 199 | 136 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | 713fab2e946b300d21215aff1553785e8857ce65 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.39e-05 | 199 | 136 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | ffd5b4d58d81b76e01d87016209f16879d81c592 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 200 | 136 | 6 | d8459e45a8396a9ee063666a1928c649162c5727 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-05 | 132 | 136 | 5 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 6.58e-05 | 138 | 136 | 5 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Sc17a7.Oprk1_(Claustrum?)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.80e-05 | 74 | 136 | 4 | 0feb6bd4c4277f62a4f596370c00ed64e79a389b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Sc17a7.Oprk1_(Claustrum?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.80e-05 | 74 | 136 | 4 | 4908cbf8ef5881a01a58c26076bd263f8a5665c2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Sc17a7.Oprk1_(Claustrum?)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.80e-05 | 74 | 136 | 4 | c26fdce3f979a2f5280a6adcc980419389aec3cb | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 151 | 136 | 5 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 158 | 136 | 5 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-04 | 159 | 136 | 5 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 161 | 136 | 5 | 5cb91ae9674b370a27be0d5852c3816b4434239e | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 161 | 136 | 5 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-04 | 164 | 136 | 5 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 165 | 136 | 5 | 01c6355177d79b4523c8b20366e20b2b62c6d08d | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 165 | 136 | 5 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-04 | 165 | 136 | 5 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 165 | 136 | 5 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 166 | 136 | 5 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 166 | 136 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 166 | 136 | 5 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 166 | 136 | 5 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.61e-04 | 167 | 136 | 5 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.66e-04 | 168 | 136 | 5 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 168 | 136 | 5 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 168 | 136 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 168 | 136 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.66e-04 | 168 | 136 | 5 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 168 | 136 | 5 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 168 | 136 | 5 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 168 | 136 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 136 | 5 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 136 | 5 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 136 | 5 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 136 | 5 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 172 | 136 | 5 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 172 | 136 | 5 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 172 | 136 | 5 | eaba10a4d4eaab42ad2e2da65ebb20b50edaf815 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 136 | 5 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 174 | 136 | 5 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-04 | 174 | 136 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.95e-04 | 174 | 136 | 5 | 5ec8a48a390379d6c422120dce46437a77da67cc | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 175 | 136 | 5 | 3bca1aac2a2a1f46753b5f9462888f144ed8327b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 175 | 136 | 5 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-04 | 175 | 136 | 5 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 176 | 136 | 5 | d54543510c804474c5c32e007cd699e75fc5aaba | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 177 | 136 | 5 | 7bc92314b22a876296a4e2db51e7fb0fdfd69379 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 177 | 136 | 5 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | control-NK_CD56bright|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-04 | 178 | 136 | 5 | f3d0bc9a39ed94785676f10c285c5b031bc93aae | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class （2021.01.30） | 2.17e-04 | 178 | 136 | 5 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 179 | 136 | 5 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-04 | 179 | 136 | 5 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 179 | 136 | 5 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-04 | 179 | 136 | 5 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 136 | 5 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 136 | 5 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 136 | 5 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-04 | 181 | 136 | 5 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-04 | 181 | 136 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.34e-04 | 181 | 136 | 5 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 181 | 136 | 5 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.34e-04 | 181 | 136 | 5 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 182 | 136 | 5 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-04 | 182 | 136 | 5 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 182 | 136 | 5 | fe4fb213dc0ca482b0f94097fe1b0a51fc2690e2 | |
| ToppCell | HSPCs-Neutro_prog.|World / Lineage and Cell class | 2.40e-04 | 182 | 136 | 5 | f2512354b90f55bf4172c28084bf52cf79e41d8a | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 182 | 136 | 5 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 182 | 136 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 183 | 136 | 5 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| Computational | Genes in the cancer module 288. | 2.80e-06 | 37 | 66 | 5 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | 1.02e-05 | 124 | 66 | 7 | MODULE_289 | |
| Computational | Genes in the cancer module 146. | 3.61e-05 | 102 | 66 | 6 | MODULE_146 | |
| Computational | GPCR signaling pathways (immune and neuro). | 2.20e-04 | 90 | 66 | 5 | MODULE_375 | |
| Computational | Neighborhood of JAG1 | 2.83e-04 | 95 | 66 | 5 | MORF_JAG1 | |
| Computational | Neighborhood of SMARCD1 | 4.50e-04 | 105 | 66 | 5 | GCM_SMARCD1 | |
| Computational | Genes in the cancer module 134. | 7.97e-04 | 30 | 66 | 3 | MODULE_134 | |
| Drug | tetradotoxin | SCN11A DRD2 DRD3 HTR2B MLNR COX8A PTCH1 GRM4 EDNRA OPRK1 ADORA1 ADORA2A SCN3A SCN10A KCNMB4 TACR1 | 7.59e-09 | 428 | 138 | 16 | CID000020382 |
| Drug | [11c]mpdx | 1.92e-08 | 6 | 138 | 4 | CID005461877 | |
| Drug | [11c]tmsx | 1.59e-07 | 9 | 138 | 4 | CID005461878 | |
| Drug | A804090 | 2.18e-07 | 3 | 138 | 3 | CID002724878 | |
| Drug | SB-277011 | 2.18e-07 | 3 | 138 | 3 | CID005311096 | |
| Drug | Lys-pro-val | 2.64e-07 | 10 | 138 | 4 | CID000125672 | |
| Drug | AC1L9NAZ | 3.71e-07 | 198 | 138 | 10 | CID000449606 | |
| Drug | AC1L1CBF | DRD2 DRD3 MC1R MC2R MC4R MC5R EDNRA OPRK1 ADORA1 ADORA2A SCTR TACR1 | 1.01e-06 | 336 | 138 | 12 | CID000001822 |
| Drug | A 86929 | 1.67e-06 | 15 | 138 | 4 | ctd:C095427 | |
| Drug | pentazocine HCl | 1.84e-06 | 34 | 138 | 5 | CID000004736 | |
| Drug | embitol | 2.16e-06 | 5 | 138 | 3 | CID000005928 | |
| Drug | AH 21-132 | 2.84e-06 | 37 | 138 | 5 | CID003035793 | |
| Drug | GTP[S] | DRD2 OXER1 DRD3 MLNR GRM4 OPRK1 ADORA1 ADORA2A TGM2 MLC1 SCN3A AGTR2 SCN10A TACR1 GPR45 | 3.16e-06 | 591 | 138 | 15 | CID000001764 |
| Drug | forskolin from Coleus forskohlii | AANAT PRLHR DRD2 OXER1 DRD3 MC1R MC2R MC4R MC5R NMUR2 PTCH1 GRM4 EDNRA TBC1D9 OPRK1 ADORA1 ADORA2A SCN3A SCN10A SCTR | 3.19e-06 | 1013 | 138 | 20 | CID000003413 |
| Drug | spirodecanone | 3.70e-06 | 18 | 138 | 4 | CID000070556 | |
| Drug | His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 4.30e-06 | 6 | 138 | 3 | CID003010021 | |
| Drug | SB 200646A | 4.67e-06 | 19 | 138 | 4 | CID000126769 | |
| Drug | thulium | 5.18e-06 | 111 | 138 | 7 | CID000023961 | |
| Drug | deoxycorticosterone | 5.18e-06 | 111 | 138 | 7 | CID000006166 | |
| Drug | 4pal | 5.81e-06 | 20 | 138 | 4 | CID005748175 | |
| Drug | Acth (4-10) | 7.14e-06 | 21 | 138 | 4 | CID000123787 | |
| Drug | Acth (6-9) | 7.49e-06 | 7 | 138 | 3 | CID000160744 | |
| Drug | flumezapine | 7.49e-06 | 7 | 138 | 3 | CID000043602 | |
| Drug | Acth(11-24) | 8.68e-06 | 22 | 138 | 4 | CID003037130 | |
| Drug | PL 0 | 1.25e-05 | 24 | 138 | 4 | CID000016157 | |
| Drug | acetylcholine | DRD2 DRD3 MLNR EDNRA OPRK1 ADORA1 ADORA2A NOX1 AGTR2 KCNMB4 TACR1 | 1.31e-05 | 361 | 138 | 11 | CID000000187 |
| Drug | fenfluramine | 1.33e-05 | 178 | 138 | 8 | CID000003337 | |
| Drug | isopentenyl diphosphate | 1.71e-05 | 89 | 138 | 6 | CID000001195 | |
| Drug | Shu 9119 | 1.74e-05 | 26 | 138 | 4 | CID006440621 | |
| Drug | Haatpln | 1.78e-05 | 9 | 138 | 3 | CID005487257 | |
| Drug | lysine salicylate | 1.78e-05 | 9 | 138 | 3 | CID003080858 | |
| Drug | NIASP | 1.78e-05 | 9 | 138 | 3 | CID006439184 | |
| Drug | prazosin | 2.39e-05 | 193 | 138 | 8 | CID000004893 | |
| Drug | indole | 2.53e-05 | 10 | 138 | 3 | ctd:C030374 | |
| Drug | 2-(di-n-propylamino)tetralin | 2.53e-05 | 10 | 138 | 3 | CID000090285 | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 3195_UP | |
| Drug | phentolamine | 3.08e-05 | 200 | 138 | 8 | CID000005775 | |
| Drug | His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH2 | 3.47e-05 | 11 | 138 | 3 | CID005311279 | |
| Drug | L-368,899 | 3.47e-05 | 11 | 138 | 3 | CID000132857 | |
| Drug | mesulergine | 3.58e-05 | 31 | 138 | 4 | CID000068848 | |
| Drug | Sulpiride | 3.65e-05 | 2 | 138 | 2 | DB00391 | |
| Drug | N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride | 3.65e-05 | 2 | 138 | 2 | ctd:C016868 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 3.65e-05 | 2 | 138 | 2 | ctd:C051171 | |
| Drug | CGS 15855A | 3.65e-05 | 2 | 138 | 2 | ctd:C051347 | |
| Drug | (5,6-dimethoxyindan-2-yl)dipropylamine | 3.65e-05 | 2 | 138 | 2 | ctd:C086335 | |
| Drug | Domperidone | 3.65e-05 | 2 | 138 | 2 | DB01184 | |
| Drug | O265 | 3.65e-05 | 2 | 138 | 2 | CID000006871 | |
| Drug | UH 232 | 3.65e-05 | 2 | 138 | 2 | ctd:C045971 | |
| Drug | 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline | 3.65e-05 | 2 | 138 | 2 | ctd:C416545 | |
| Drug | 5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one | 3.65e-05 | 2 | 138 | 2 | ctd:C524699 | |
| Drug | 6-amino-1,3-dimethyluracil | 3.65e-05 | 2 | 138 | 2 | CID000081152 | |
| Drug | 3-(3-cyanophenyl)-N-n-propylpiperidine | 3.65e-05 | 2 | 138 | 2 | ctd:C094012 | |
| Drug | iodosulpride | 3.65e-05 | 2 | 138 | 2 | ctd:C045105 | |
| Drug | fluoroclebopride | 3.65e-05 | 2 | 138 | 2 | ctd:C083673 | |
| Drug | 2-amino-4-phenyl-8-pyrrolidin-1-ylmethylindeno(1,2-d)pyrimidin-5-one | 3.65e-05 | 2 | 138 | 2 | ctd:C562225 | |
| Drug | trimethoxymethane | 3.65e-05 | 2 | 138 | 2 | CID000009005 | |
| Drug | GR 218231 | 3.65e-05 | 2 | 138 | 2 | ctd:C408390 | |
| Drug | N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide | 3.65e-05 | 2 | 138 | 2 | ctd:C539157 | |
| Drug | Piribedil | 3.65e-05 | 2 | 138 | 2 | ctd:D010891 | |
| Drug | AC1L31N6 | 3.65e-05 | 2 | 138 | 2 | CID000132830 | |
| Drug | YM-09151-2 | 4.07e-05 | 32 | 138 | 4 | CID000004452 | |
| Drug | nM-1 | 4.55e-05 | 155 | 138 | 7 | CID000445754 | |
| Drug | Chlorprothixene | 4.61e-05 | 12 | 138 | 3 | DB01239 | |
| Drug | ocaperidone | 4.61e-05 | 12 | 138 | 3 | CID000071351 | |
| Drug | EN-1530 | 5.15e-05 | 278 | 138 | 9 | CID000004425 | |
| Drug | A-I-J | 5.20e-05 | 34 | 138 | 4 | CID000449208 | |
| Drug | atropine sulfate | 5.23e-05 | 347 | 138 | 10 | CID000003661 | |
| Drug | SKF 38393 | 5.68e-05 | 110 | 138 | 6 | CID000001242 | |
| Drug | Bim 22015 | 5.96e-05 | 13 | 138 | 3 | CID000132380 | |
| Drug | l-stepholidine | 6.55e-05 | 36 | 138 | 4 | CID000005290 | |
| Drug | Lisuride | 7.55e-05 | 14 | 138 | 3 | DB00589 | |
| Drug | Pramipexole | 7.55e-05 | 14 | 138 | 3 | DB00413 | |
| Drug | Ropinirole | 7.55e-05 | 14 | 138 | 3 | DB00268 | |
| Drug | naphthyridine | 7.55e-05 | 14 | 138 | 3 | CID000136069 | |
| Drug | YM348 | 7.55e-05 | 14 | 138 | 3 | CID003045225 | |
| Drug | CY 208-243 | 7.55e-05 | 14 | 138 | 3 | CID000058144 | |
| Drug | SCH 23390 | 7.64e-05 | 116 | 138 | 6 | CID000005018 | |
| Drug | norbiotin | 7.68e-05 | 72 | 138 | 5 | CID000446903 | |
| Drug | pipamperone | 8.13e-05 | 38 | 138 | 4 | CID000004830 | |
| Drug | MK-801 | 8.33e-05 | 296 | 138 | 9 | CID000001207 | |
| Drug | Nicorette | AANAT DRD2 DRD3 HTR2B MC1R GRM4 EDNRA OPRK1 ADORA1 ADORA2A SCN3A SCN10A | 9.39e-05 | 529 | 138 | 12 | CID000000942 |
| Drug | Cabergoline | 9.40e-05 | 15 | 138 | 3 | DB00248 | |
| Drug | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 9.40e-05 | 15 | 138 | 3 | ctd:D020875 | |
| Drug | Apomorphine | 9.40e-05 | 15 | 138 | 3 | DB00714 | |
| Drug | mitragynine | 9.40e-05 | 15 | 138 | 3 | ctd:C001801 | |
| Drug | Gabrene | 9.97e-05 | 40 | 138 | 4 | CID005361323 | |
| Drug | methiothepin | 1.06e-04 | 77 | 138 | 5 | CID000004106 | |
| Drug | (1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate) | 1.09e-04 | 3 | 138 | 2 | ctd:C461261 | |
| Drug | 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline | 1.09e-04 | 3 | 138 | 2 | ctd:C110041 | |
| Drug | DP-6OH-3CA | 1.09e-04 | 3 | 138 | 2 | CID000086146 | |
| Drug | Neuriplege | 1.09e-04 | 3 | 138 | 2 | CID000065750 | |
| Drug | 7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan | 1.09e-04 | 3 | 138 | 2 | ctd:C090812 | |
| Drug | Theobromine | 1.09e-04 | 3 | 138 | 2 | DB01412 | |
| Drug | 1-allylisoguanosine | 1.09e-04 | 3 | 138 | 2 | CID006438736 | |
| Drug | Ketamine | 1.09e-04 | 3 | 138 | 2 | DB01221 | |
| Drug | 3,7-dimethyl-1-propargylxanthine | 1.09e-04 | 3 | 138 | 2 | ctd:C057837 | |
| Drug | 7-hydroxy-2-N,N-dipropylaminotetralin | 1.09e-04 | 3 | 138 | 2 | ctd:C031349 | |
| Drug | 2-PEMA | 1.09e-04 | 3 | 138 | 2 | CID003025817 | |
| Drug | 3-N-methylspiperone | 1.09e-04 | 3 | 138 | 2 | ctd:C039167 | |
| Drug | quinelorane | 1.09e-04 | 3 | 138 | 2 | ctd:C047726 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.99e-07 | 157 | 133 | 8 | DOID:14330 (implicated_via_orthology) | |
| Disease | Ventricular Dysfunction | 4.93e-06 | 8 | 133 | 3 | C0242973 | |
| Disease | Withdrawal Symptoms | 6.53e-06 | 58 | 133 | 5 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 6.53e-06 | 58 | 133 | 5 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 6.53e-06 | 58 | 133 | 5 | C0038587 | |
| Disease | Depressive disorder | 6.90e-06 | 289 | 133 | 9 | C0011581 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Brain Tumor, Primary | 1.46e-05 | 33 | 133 | 4 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.46e-05 | 33 | 133 | 4 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.46e-05 | 33 | 133 | 4 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 1.46e-05 | 33 | 133 | 4 | C0496899 | |
| Disease | Neoplasms, Intracranial | 1.46e-05 | 33 | 133 | 4 | C1527390 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.91e-05 | 12 | 133 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Mental Depression | 2.10e-05 | 254 | 133 | 8 | C0011570 | |
| Disease | Hypertensive disease | 2.58e-05 | 190 | 133 | 7 | C0020538 | |
| Disease | Malignant neoplasm of brain | 2.59e-05 | 38 | 133 | 4 | C0153633 | |
| Disease | Brain Neoplasms | 2.87e-05 | 39 | 133 | 4 | C0006118 | |
| Disease | Allodynia | 4.00e-05 | 84 | 133 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 4.00e-05 | 84 | 133 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 4.00e-05 | 84 | 133 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 4.00e-05 | 84 | 133 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 4.00e-05 | 84 | 133 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 4.00e-05 | 84 | 133 | 5 | C0751213 | |
| Disease | Hyperalgesia | 4.00e-05 | 84 | 133 | 5 | C0020429 | |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 6.03e-05 | 3 | 133 | 2 | C0021122 | |
| Disease | Primary Erythermalgia | 6.03e-05 | 3 | 133 | 2 | C0014805 | |
| Disease | Epilepsies, Partial | 6.03e-05 | 3 | 133 | 2 | C0014547 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 6.03e-05 | 3 | 133 | 2 | C1833661 | |
| Disease | Intermittent Explosive Disorder | 6.03e-05 | 3 | 133 | 2 | C0021776 | |
| Disease | Seizures, Focal | 1.11e-04 | 104 | 133 | 5 | C0751495 | |
| Disease | Tonic - clonic seizures | 1.11e-04 | 104 | 133 | 5 | C0494475 | |
| Disease | focal epilepsy (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:2234 (is_implicated_in) | |
| Disease | thioproline measurement | 1.20e-04 | 4 | 133 | 2 | EFO_0801012 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.20e-04 | 4 | 133 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Etat Marbre | 1.48e-04 | 23 | 133 | 3 | C0266487 | |
| Disease | Anhedonia | 1.69e-04 | 24 | 133 | 3 | C0178417 | |
| Disease | Schizophrenia | DRD2 DRD3 MC5R GRM4 IL18R1 CNIH3 ADORA1 ADORA2A TGM2 SLC26A8 MLC1 ALK SLC23A3 | 1.85e-04 | 883 | 133 | 13 | C0036341 |
| Disease | heroin dependence (biomarker_via_orthology) | 2.00e-04 | 5 | 133 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | Bradycardia | 2.16e-04 | 26 | 133 | 3 | C0428977 | |
| Disease | Alcoholic Intoxication, Chronic | 2.22e-04 | 268 | 133 | 7 | C0001973 | |
| Disease | Movement Disorders | 3.00e-04 | 29 | 133 | 3 | C0026650 | |
| Disease | Child Development Disorders, Specific | 3.00e-04 | 29 | 133 | 3 | C0085997 | |
| Disease | Child Development Deviations | 3.00e-04 | 29 | 133 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 3.32e-04 | 30 | 133 | 3 | C0008073 | |
| Disease | Hyperkinesia | 4.04e-04 | 32 | 133 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 4.04e-04 | 32 | 133 | 3 | C0751217 | |
| Disease | Congenital Pain Insensitivity | 4.17e-04 | 7 | 133 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.17e-04 | 7 | 133 | 2 | C0020075 | |
| Disease | Recurrent depression | 7.11e-04 | 9 | 133 | 2 | C0221480 | |
| Disease | Delirium | 8.86e-04 | 10 | 133 | 2 | C0011206 | |
| Disease | Mood Disorders | 1.01e-03 | 168 | 133 | 5 | C0525045 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 1.11e-03 | 45 | 133 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | Generalized seizures | 1.15e-03 | 101 | 133 | 4 | C0234533 | |
| Disease | Clonic Seizures | 1.15e-03 | 101 | 133 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 1.15e-03 | 101 | 133 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 1.15e-03 | 101 | 133 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.15e-03 | 101 | 133 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.15e-03 | 101 | 133 | 4 | C0751123 | |
| Disease | Complex partial seizures | 1.15e-03 | 101 | 133 | 4 | C0149958 | |
| Disease | Single Seizure | 1.15e-03 | 101 | 133 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.15e-03 | 101 | 133 | 4 | C3495874 | |
| Disease | Visual seizure | 1.15e-03 | 101 | 133 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 1.15e-03 | 101 | 133 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 1.15e-03 | 101 | 133 | 4 | C0422855 | |
| Disease | Gustatory seizure | 1.15e-03 | 101 | 133 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.15e-03 | 101 | 133 | 4 | C0422850 | |
| Disease | Olfactory seizure | 1.15e-03 | 101 | 133 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 1.15e-03 | 101 | 133 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.15e-03 | 101 | 133 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 1.15e-03 | 101 | 133 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 1.15e-03 | 101 | 133 | 4 | C4317109 | |
| Disease | Absence Seizures | 1.19e-03 | 102 | 133 | 4 | C4316903 | |
| Disease | Convulsions | 1.19e-03 | 102 | 133 | 4 | C4048158 | |
| Disease | Tonic Seizures | 1.19e-03 | 102 | 133 | 4 | C0270844 | |
| Disease | Myoclonic Seizures | 1.28e-03 | 104 | 133 | 4 | C4317123 | |
| Disease | Lenticulostriate Disorders | 1.29e-03 | 12 | 133 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 1.29e-03 | 12 | 133 | 2 | C0015371 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.29e-03 | 12 | 133 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Basal Ganglia Diseases | 1.29e-03 | 12 | 133 | 2 | C0004782 | |
| Disease | phospholipids in medium LDL measurement | 1.42e-03 | 49 | 133 | 3 | EFO_0022183 | |
| Disease | lung disease (implicated_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | total lipids in LDL measurement | 1.68e-03 | 52 | 133 | 3 | EFO_0022308 | |
| Disease | Hypotension | 1.78e-03 | 53 | 133 | 3 | C0020649 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.88e-03 | 54 | 133 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | Waxy flexibility | 2.04e-03 | 15 | 133 | 2 | C0233612 | |
| Disease | Dyskinesia, Medication-Induced | 2.04e-03 | 15 | 133 | 2 | C0751088 | |
| Disease | Catalepsy | 2.04e-03 | 15 | 133 | 2 | C0007370 | |
| Disease | Dyskinesia, Drug-Induced | 2.04e-03 | 15 | 133 | 2 | C0013386 | |
| Disease | Rhabdomyosarcoma | 2.04e-03 | 15 | 133 | 2 | C0035412 | |
| Disease | FEV change measurement, response to bronchodilator | 2.30e-03 | 58 | 133 | 3 | EFO_0005921, GO_0097366 | |
| Disease | phospholipids in small LDL measurement | 2.42e-03 | 59 | 133 | 3 | EFO_0022297 | |
| Disease | hypertension (implicated_via_orthology) | 2.73e-03 | 128 | 133 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.92e-03 | 63 | 133 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | Global developmental delay | 3.14e-03 | 133 | 133 | 4 | C0557874 | |
| Disease | Seizures | 3.14e-03 | 218 | 133 | 5 | C0036572 | |
| Disease | systemic lupus erythematosus | PRSS54 SLC17A2 WDFY4 CXCR5 SLC7A8 GTF2H1 TRMT44 CD226 SCN10A TARBP1 | 3.41e-03 | 799 | 133 | 10 | MONDO_0007915 |
| Disease | Malignant neoplasm of breast | NPBWR1 TMPRSS6 DGKE PHGDH EDNRA PIK3R4 CXCR5 GPR180 TGM2 ALK CDH10 GPR45 | 3.45e-03 | 1074 | 133 | 12 | C0006142 |
| Disease | Alcohol abuse | 3.47e-03 | 67 | 133 | 3 | C0085762 | |
| Disease | Cocaine Dependence | 3.67e-03 | 139 | 133 | 4 | C0600427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THLLFLPDWAAVFEL | 431 | Q5NDL2 | |
| VLCPAWLFLDVLFST | 126 | P41595 | |
| FLPEEAWCDLTIHLP | 3201 | Q9NR09 | |
| CWSPYHIVIFLDTLA | 271 | P32302 | |
| FPKLVTTETGWLCLH | 96 | Q9UBJ2 | |
| FLFALSWLPLHILNC | 241 | P30542 | |
| AIIVGLFALCWLPLH | 236 | P29274 | |
| WLPLHIINCFTFFCP | 246 | P29274 | |
| LFFPDVWHCLPTRSE | 571 | Q8IX12 | |
| SIVWVHAFPELFLSC | 151 | Q9UBB4 | |
| RHAELCFLDVIPFWK | 256 | Q9HC16 | |
| LLGICVWFVVDPSHS | 711 | Q14833 | |
| FLAFCVWLTLPGAET | 6 | P48960 | |
| VVLAFIICWLPFHVL | 261 | P50052 | |
| IICWLPFHVLTFLDA | 266 | P50052 | |
| FSWNLCLPTPAHFLD | 186 | Q8IV13 | |
| LVVIFALCWFPLHLS | 311 | P25101 | |
| HHEFFPPWLLLLCSA | 221 | Q9ULJ7 | |
| HLDLLPFLEQLYCWA | 101 | Q96M86 | |
| HVALCIKLIAAWFVP | 711 | A1A5B4 | |
| CILSHLPWFEVFYKL | 96 | Q8IV53 | |
| LTVPWLVEFLSFADH | 691 | Q8IWY9 | |
| LWDPNEFAVHCFKII | 266 | Q14156 | |
| RGFPCSLWVLFHFLT | 401 | O00391 | |
| EDLSCWFPPSHIFSV | 76 | P52333 | |
| PFTILLFFLLHRWCS | 256 | P43631 | |
| FLCWGPFFLHLTLIV | 251 | Q01726 | |
| FALSFSRWLCAHPEL | 446 | Q9ULE6 | |
| CIWLLVLSFIGGFLH | 141 | P0DN80 | |
| FLLVFSLWSEPVVCG | 436 | Q9UHI5 | |
| FVNCPSISLLEWHPF | 326 | Q9Y5S8 | |
| PGLEAAHFWIAIPFC | 21 | Q9H346 | |
| GLETLHIWIGFPFCA | 21 | Q8NGJ4 | |
| GLDTLHIWISFPFCI | 21 | Q8NGH9 | |
| HIWISFPFCIVYLIA | 26 | Q8NGH9 | |
| TCWIFSFLLALVHIT | 146 | Q8NGT7 | |
| IALHDCVLEFWPVEL | 76 | Q13478 | |
| PFTILLFFLLHRWCS | 256 | P43632 | |
| VFAICWAPFHIDRLF | 276 | Q9GZQ4 | |
| PSASLDFLWACIHVP | 1691 | Q8N201 | |
| LLVHCISGWDRTPLF | 326 | Q8NCE2 | |
| FIPVFLNCWLAKHAL | 216 | Q5JUK3 | |
| VHPVIWSLTSLPFDC | 251 | Q10570 | |
| HLIAAFWAPVCAFLA | 56 | Q8IWD5 | |
| TEAWLLGPVACHLLF | 101 | Q5NUL3 | |
| ALLHAVCFSAVKEPW | 1011 | A6NKB5 | |
| HGWISIPFCFIYLTV | 26 | Q8NGK1 | |
| CLSTLPTVLGIFWFD | 76 | Q8NGK1 | |
| LTAFPGLECAHVWIS | 16 | Q8NGJ9 | |
| IFWFHLPEISFDACL | 86 | Q9H2C5 | |
| GLEAYHIWLSIPLCL | 21 | Q96RD2 | |
| LHFVHCFLPVAEGWA | 1041 | Q92614 | |
| CHPFLAWFFCLLLVP | 381 | P39060 | |
| INSWLEVSFCLPHKI | 221 | Q12980 | |
| FPFLIDGTWHHDCIL | 171 | O60449 | |
| PFTILLFFLLHRWCS | 256 | Q14952 | |
| FWPLNSHFCTALVSL | 96 | Q96P66 | |
| LWFLCHPVLACISVI | 366 | Q86V85 | |
| GLEATHIWISLPFCF | 21 | Q8NGI0 | |
| IDSFVIWGCATRLFP | 216 | P24158 | |
| HLAFGCILSEFWVLS | 66 | Q6PEW0 | |
| IGLPLLAFDFHWCTN | 71 | Q6ZMK1 | |
| SVAEIFDCLGPHFTW | 51 | Q02509 | |
| LCWTPFHLASVVALT | 271 | P48146 | |
| ILFVGFSLCWLPHSV | 271 | Q9Y5Y3 | |
| LDPAWHLLFDGCNLT | 191 | Q9H8H3 | |
| SLALFIFCIHTRPWT | 111 | Q8TDS5 | |
| PFTILLFFLLHRWCS | 256 | Q14953 | |
| FLLLFLFWVCLPHFC | 6 | Q9Y6N8 | |
| EWALGLLHVLLSCTF | 371 | Q5T197 | |
| FLVCWLPYHVAVLLD | 261 | P25106 | |
| IGVFVVCWAPFFLHL | 251 | P32245 | |
| VFTVCWAPFFLHLTL | 246 | P33032 | |
| SCFVTFLLPAGWILS | 46 | P10176 | |
| DEIVLLHCFLWPLVT | 166 | Q86W47 | |
| LHCFLWPLVTFVVGV | 171 | Q86W47 | |
| WGLATHPFKDLLLTC | 596 | Q9HC35 | |
| VFIICWLPFFITHIL | 381 | P14416 | |
| WLPFFITHILNIHCD | 386 | P14416 | |
| IEFLTTRAFGPLWCH | 1796 | Q5TBA9 | |
| TFHVPWKRLLLCDFA | 11 | Q8IXQ3 | |
| LFADGHLILWTLCSV | 16 | P52429 | |
| ALCEEVLWHTSVPFA | 16 | Q15762 | |
| LCWFAVCGFIHLVIE | 66 | Q15125 | |
| FLHSVFLEGPVESWL | 1596 | Q9P225 | |
| EIFNCIFDAHVPPLW | 4226 | Q9P225 | |
| WHLVGTVCVLLSFPF | 96 | Q6NUT3 | |
| GAFIVCWLPFFLTHV | 336 | P35462 | |
| LVVVLAFIICWLPFH | 301 | O43193 | |
| AFIICWLPFHVGRII | 306 | O43193 | |
| LLCWTPYHLSTVVAL | 261 | P48145 | |
| PVVFLTHCNWIFSLL | 1371 | Q9P2P1 | |
| PRAINHFFCDIAPWI | 171 | Q8NGZ6 | |
| PFTILLFFLLHRWCS | 256 | Q14954 | |
| CWTPIHIFILVEALG | 286 | P41145 | |
| GLEHLHAWISIPFCF | 21 | Q8NGK4 | |
| HIWISIPFCLAYTLA | 26 | Q8NGK3 | |
| GLEDVHLWISFPLCT | 21 | Q8NH53 | |
| VLFHTVRFGALSCWL | 686 | Q92918 | |
| HPIFSLNWECVVSFL | 901 | P11717 | |
| VILWTPLLFRHFCQE | 236 | Q92521 | |
| HFLDLADFPRECILW | 326 | Q86SS6 | |
| WESVIYLCAAVHPII | 281 | P59551 | |
| FISVLIFCPERWHSD | 246 | Q8IYL2 | |
| CWVELVAIHLFSPGT | 176 | Q8TEB9 | |
| VFAVCWLPLHVFNLL | 286 | P49683 | |
| RHFLTLCPELSLGWF | 71 | Q16613 | |
| LGACVVELELPSHWF | 181 | Q24JP5 | |
| CSLAHIFPVEDLWTK | 596 | B5MCY1 | |
| LLLYWAPRFCVTHSA | 501 | Q8NE09 | |
| WVIIKGCSPFLDHDV | 16 | Q587J7 | |
| WHRFLRCVLTIFPFL | 66 | Q96RN1 | |
| TFAICWLPFHIFFLL | 256 | P25103 | |
| PFTILLFFLLHRWCS | 351 | Q14943 | |
| HWLLLFISVVLACTF | 1026 | Q13635 | |
| ELCEEVHLFGFWAFP | 311 | O15466 | |
| HSFLIVFRVLCGEWI | 931 | Q9NY46 | |
| EVAQFCFTHWGLALL | 211 | Q6PIS1 | |
| LKEIHFLAWASAFCP | 206 | Q6UX72 | |
| IFDPTVHWLFTTCGA | 676 | Q9UM73 | |
| GVFIFCWAPFVLHVL | 226 | Q01718 | |
| LIFWIPFSILVHCVD | 681 | P78536 | |
| SHVWRPAALFLTLLC | 36 | Q5QGZ9 | |
| LCAALIFFAIWHIIA | 16 | Q8TBE1 | |
| FASDIAPFLCHPNLW | 656 | Q99570 | |
| VLGHFILLFNAWCPA | 131 | P21980 | |
| FLFHCGVINPSWSEL | 2201 | Q63HN8 | |
| VLAAIFCRPHEWEVL | 11 | Q9Y3V2 | |
| VAVGELLRHFWSCFP | 466 | P32780 | |
| LAAPLLILWFHLDCV | 6 | A0A0B4J272 | |
| LLCDFEVWLHAPYEL | 1501 | Q8IZQ1 | |
| FHSFLIVFRILCGEW | 836 | Q9Y5Y9 | |
| FDLHILVCTFPAGLW | 416 | Q8TCJ2 | |
| HWLDIDPNFICLSGL | 21 | Q6ZQQ2 | |
| PAIFVALWAIARHFL | 266 | P47872 | |
| ALLFPWACGTHSDVL | 876 | Q6ZT07 | |
| TCLPLWAIFLGFFSH | 271 | O00624 | |
| FLKAWEHSVGIICFP | 76 | Q6ZS81 | |
| PLDSNEFWVHEGCIL | 1846 | Q9UGU0 | |
| PLWRDVIATFTDHCI | 2216 | O43149 | |
| SHLLFAVGCPLLLLW | 946 | Q8TEQ8 | |
| HSFLVVFRILCGEWI | 756 | Q9UI33 | |
| IWPLCDFITVHTPLL | 196 | O43175 | |
| HWCAVPILFLSKALA | 481 | Q13395 | |
| ECLAHLFSWIPLSAS | 251 | Q96QU8 | |
| ICGLLPWIDNIAHIF | 761 | Q6PJF5 | |
| LLLSCPAFWAHFARL | 136 | Q2T9J0 | |
| LEAGDVLFIPALWFH | 221 | A2RUC4 | |
| ARSHFFEPGLHCWIT | 691 | Q8IU80 | |
| PHLSVTFFWILVACF | 226 | Q15049 | |
| EHFISILGKCFDSPW | 156 | Q8TDW0 |